Carl L. Gordon - Insider Trading & Ownership

Entity: Individual
Location: 601 Lexington Avenue, 54 Th Floor, New York, NY
Summary: The estimated net worth of Carl L. Gordon is at least $30M dollars as of November 5, 2024. Carl L. Gordon is the Director of Venetian-1 Acquisition Corp. and owns shares of Venetian-1 Acquisition Corp. stock worth about $10.7M. Carl L. Gordon is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $7.56M. Carl L. Gordon is the Director, 10%+ Owner of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $5.52M. Carl L. Gordon is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $5.26M. Carl L. Gordon is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $942K.
All Insider Reports: All Insider Reports

Ownership of Carl L. Gordon

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NONE	Venetian-1 Acquisition Corp.	Director	$10.7M			Nov 1, 2024
TERN	Terns Pharmaceuticals, Inc.	Director, 10%+ Owner	$7.56M	-$562K	-6.92%	Jul 15, 2024
AVBP	ArriVent BioPharma, Inc.	Director, 10%+ Owner	$5.52M			Jan 30, 2024
KROS	Keros Therapeutics, Inc.	Director	$5.26M	-$11M	-67.7%	Aug 13, 2024
ACET	Adicet Bio, Inc.	Director, 10%+ Owner	$942K	+$7.5M		Aug 21, 2024
KNTE	Kinnate Biopharma Inc.	Director, 10%+ Owner	$0			Apr 3, 2024
THRX	Theseus Pharmaceuticals, Inc.	Director, 10%+ Owner	$0			Feb 14, 2024
CMPX	Compass Therapeutics, Inc.	Director, 10%+ Owner				Feb 9, 2024
IRON	Disc Medicine, Inc.	Director, 10%+ Owner				Oct 4, 2021
MBX	MBX Biosciences, Inc.	Director, 10%+ Owner				Sep 16, 2024
ORIC	Oric Pharmaceuticals, Inc.	Director, 10%+ Owner				Jun 16, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.